Leukocyte cell-derived chemotaxin 2 inhibits development of atherosclerosis in mice
Leukocyte cell-derived chemotaxin 2 inhibits development of atherosclerosis in mice
复制标题
白细胞来源的趋化因子2抑制小鼠动脉粥样硬化的发展
DOI:
10.24272/j.issn.2095-8137.2019.030
复制
发表时间:
2019-07
影响因子:
4.9
通讯作者:
Wang J A
中科院分区:
文献类型:
--
作者:
He W M;Dai T;Chen J;Wang J A
Leukocyte cell-derived chemotaxin 2 (LECT2), a multifunctional hepatokine, is involved in many pathological conditions. However, its role in atherosclerosis remains undefined. In this study, we administered vehicle or LECT2 to male Apoe-/- mice fed a Western diet for 15 weeks. Atherosclerotic lesions were visualized and quantified with Oil-red O and hematoxylin staining. The mRNA expression levels of MCP-1, MMP-1, IL-8, IL-1β, and TNF-α were analyzed by quantitative real-time polymerase chain reaction. Serum TNF-α, IL-1β, IL-8, MCP-1, and MMP-1 concentrations were measured by enzyme-linked immunosorbent assay. CD68, CD31, and α-SMA, markers of macrophages, endothelial cells, and smooth muscle cells, respectively, were detected by immunostaining. Results showed that LECT2 reduced total cholesterol and low-density lipoprotein concentrations in serum and inhibited the development of atherosclerotic lesions, accompanied by reductions in inflammatory cytokines and lower MCP-1, MMP-1, TNF-α, IL-8, and IL-1β mRNA abundance. Furthermore, LECT2 decreased CD68, but increased α-SMA in atherosclerotic lesions, suggesting an increase in smooth muscle cells and reduction in macrophages. In summary, LECT2 inhibited the development of atherosclerosis in mice, accompanied by reduced serum total cholesterol concentration and lower inflammatory responses.
登录
查看更多内容
影响因子:
64.5
作者:
Moore KJ;Tabas I
通讯作者:
Tabas I
影响因子:
13.5
作者:
L'Hermitte, Antoine;Pham, Sandrine;Couty, Jean-Pierre
通讯作者:
Couty, Jean-Pierre
影响因子:
7.3
作者:
Engelking LJ;Cantoria MJ;Xu Y;Liang G
通讯作者:
Liang G
影响因子:
2
作者:
Johnson, Jason Lee
通讯作者:
Johnson, Jason Lee
影响因子:
3.5
作者:
M. Ezzati
通讯作者:
M. Ezzati